IL-Yang Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares IL-Yang Pharmaceutical Company Limited with three other
companies in this sector in South Korea:
Daewon Pharmaceutical Co Ltd
sales of 240.72 billion Korean Won [US$213.28 million]
of which 99%
KolmarBNH Co Ltd
(256.01 billion Korean Won [US$226.82 million]
of which 90%
was Biotech), and
Samjin Pharmaceutical Company Limited
(239.31 billion Korean Won [US$212.03 million]
of which 100%
IL-Yang Pharmaceutical Company Limited reported sales of 261.61 billion Korean Won (US$231.79 million)
December of 2016.
increase of 5.3%
versus 2015, when the company's sales were 248.38 billion Korean Won.
Sales at IL-Yang Pharmaceutical Company Limited have increased during each of the previous five years
(and since 2011, sales have increased a total of 89%).